Physician profile
Brian Waldron
NPI 1801560354
$1,418.23
in general payments reported to CMS, 2019-2025
19 companies · $52.79 in 2025
The $52.79 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,083 · 2023: $267 · 2024: $15.54 · 2025: $52.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $405.49 | 2022-2025 | |
| Galderma Laboratories, L.P. | $182.13 | 2022 | |
| Lilly USA, LLC | $176.81 | 2022-2023 | Taltz, Olumiant |
| Epi Health, LLC | $95.00 | 2022 | |
| Incyte Corporation | $92.58 | 2023 | Opzelura |
| Ucb, INC. | $64.71 | 2022 | |
| Genzyme Corporation | $58.54 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $54.13 | 2022 | |
| Sun Pharmaceutical Industries INC. | $45.65 | 2022 | |
| Biofrontera INC. | $45.37 | 2022 | |
| Leo Pharma INC. | $38.15 | 2022 | |
| Organon LLC | $28.91 | 2022 | |
| Amgen INC. | $25.63 | 2022 | |
| Vanda Pharmaceuticals INC. | $23.55 | 2025 | Fanapt |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.55 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $16.47 | 2023 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.29 | 2022 | |
| Pfizer INC. | $14.40 | 2022 | |
| Kerecis Limited | $13.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Waldron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.